We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA APPROVES BOSTON SCIENTIFIC'S DRUG-ELUTING TAXUS STENT
FDA APPROVES BOSTON SCIENTIFIC'S DRUG-ELUTING TAXUS STENT
March 5, 2004
The FDA on March 4 approved Boston Scientific’s Taxus Express2 paclitaxel-eluting coronary stent system for the U.S. market, adding a fierce challenger to the highly competitive coronary stent field.